OpenAlex
PricingAboutJobs
Log inGet started
Work

Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4

HTML

Year: 2012
Type: article
Source: Blood
DOI: 10.1182/blood-2012-03-415984
Authors: Xiangao Huang, Maurizio Di Liberto, David Jayabalan, Jun Liang, Scott Ely, Jamieson Bretz, Arthur L. Shaffer, Tracey Louie, Isan Chen, Sophia Randolph, William C. Hahn, Louis M. Staudt, Ruben Niesvizky, Malcolm A. S. Moore, Selina Chen-Kiang
Institutions: Weill Cornell Medicine, National Institutes of Health, Center for Cancer Research, Pfizer (United States), Broad Institute, Harvard University, Dana-Farber Cancer Institute, Massachusetts Institute of Technology, Memorial Sloan Kettering Cancer Center
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, IRF4, bortezomib, apoptosis, building information modeling, Noxa, S phase synchronization, proteasome inhibitors, combination therapy, cell cycle regulation
SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, National Institutes of Health, U.S. Public Health Service
Award: G8440745810
OpenAlex ID: W2041694372
FWCI: 5.742
Cites: 48
Cited by: 123
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security